Sunday, August 30, 2026

AI

250 articles

C3.ai AI Stock Rebounds: Is It Time to Buy Now?

C3.ai AI Stock Rebounds: Is It Time to Buy Now?

C3.ai shares have rebounded 6% after a recent decline, sparking questions about whether it's an undervalued opportunity. With a year-to-date loss of 60.69%, investors are reassessing growth prospects. The stock's price-to-sales ratio of 5x is above industry averages, raising concerns about relative valuation.

Via News Editorial
Stock Market Rises Amid Hopes of Recovery, But AI-Driven Valuations Remain Concerning

Stock Market Rises Amid Hopes of Recovery, But AI-Driven Valuations Remain Concerning

US stock futures rose on a shortened Thanksgiving week, signaling potential recovery after a pullback amid concerns over AI-driven market rally valuations. The Dow, S&P 500, and Nasdaq all gained ground, but major indexes have lost notable ground in November as investors reassess high valuations in tech stocks.

Via News Editorial
AI Stocks Set to Outperform Apple by 2026: Key Analysis

AI Stocks Set to Outperform Apple by 2026: Key Analysis

AI stocks Alphabet and Microsoft are poised to outperform Apple by year-end 2026, according to a detailed analysis. With faster growth and lower valuations, these stocks are expected to surpass Apple's market cap.

Via News Editorial
AMD vs. Intel: Which Chipmaker Is Poised for Explosive Data Center Growth?

AMD vs. Intel: Which Chipmaker Is Poised for Explosive Data Center Growth?

AMD and Intel are at the forefront of data center competition as AI infrastructure continues to grow. AMD's MI300 and MI400 GPUs have seen significant success, while Intel's data center business has struggled. With $4.3 billion in revenue for AMD and $4.1 billion for Intel in the third quarter of 2025, AMD's full-stack approach could provide a strategic advantage over Intel.

Via News Editorial
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com